Last reviewed · How we verify

NCT05371119

BFR in Overweight Sedentary Subjects

Completed NA Last updated 12 May 2022
What this trial tests

NA trial testing Exercise Intervention in Overweight in 30 participants. Completed in 15 April 2022.

Timeline
1 February 2022
Primary endpoint
15 April 2022
15 April 2022

Quick facts

Lead sponsorUniversity of Lausanne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment30
Start date1 February 2022
Primary completion15 April 2022
Estimated completion15 April 2022
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Lausanne

Who can join

Adults 20 to 60, any sex, with Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project should allow the investigators to observe the effects of low load training under partial vascular occlusion (BFR) in comparison with resistance training at low load without partial vascular occlusion in sedentary people overweight on parameters : decrease in fat mass; increase in muscle mass 79; muscle strength; decrease in the energy cost of walking; increase in preferred walking speed; improvement in walking pattern in patients overweight. Training under partial vascular occlusion should facilitate physical activity in overweight people as it can be just as effective as a "classic" type training with heavy loads. Thus, this device could allow people for who wear heavy loads can present an obstacle to physical activity to feel more involved in the physical activity programs offered in medical or sports centers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise Intervention

Trials testing the same drug.

Other recruiting trials for Overweight

Currently open trials in the same condition.

Other University of Lausanne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05371119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing